Although the precise mechanisms of ERα transcription regulation are still under investigation, it has been clear that acquired loss of ERα transcription rather than a genetic alteration such as DNA mutations is a potential mechanism for hormone resistance in ERα-negative breast cancer [10]. Here, ESR1 is linked to breast carcinoma.